Lincoln Pharmaceuticals Reports 20% Profit Growth, Targets Rs. 1,000 Crore Revenue
Lincoln Pharmaceuticals reported a consolidated net profit of Rs. 57.50 crore for H1 FY27, marking a 20.52% year-on-year increase from Rs. 47.71 crore in H1 FY26. Total income rose 18.39% to Rs. 402.43 crore. The company aims for Rs. 1,000 crore revenue within three years, targeting 15-18% annual growth driven by cardiac, diabetic, dermatology, and ENT segments. It plans to expand exports from 60 to 90 countries, supported by recent regulatory approvals, and remains net-debt free with significant renewable energy use.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (72/100). Lens Score 36/100.
Outlets measured: thetribune, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (70–75/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 29 Oct, 11:33 am. Other outlets followed.